Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tamaril
- Development stage
- Phase 3
- Lead developer
- Marjan
- Administration
- Oral
01
Overview
**Tamaril** is a Brazilian oral herbal medicinal laxative manufactured by Marjan. It is a fixed botanical preparation containing senna (*Senna alexandrina*) leaf powder or extract, together with preparations of *Cassia fistula*, *Tamarindus indica*, *Coriandrum sativum*, and *Periandra mediterranea*. Senna-derived sennosides provide the principal stimulant-laxative activity by increasing colonic peristalsis and promoting stool softening; the other plant components contribute laxative, antispasmodic, and supportive gastrointestinal effects. Tamaril is indicated to regulate bowel function and treat constipation, including functional intestinal constipation.
- Brand names
- Tamaril
02
Targets
HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on Tamaril.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tamaril.